Editorial: A multidisciplinary approach to treatment of severe chronic airway disease (CAD): focus on biomarkers
- PMID: 38371921
- PMCID: PMC10869584
- DOI: 10.3389/falgy.2024.1357886
Editorial: A multidisciplinary approach to treatment of severe chronic airway disease (CAD): focus on biomarkers
Keywords: FeNO (Fraction of exhaled Nitric Oxide); asthma; biomarkers; monoclonal antibodies; severe asthma.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
-
- Pérez de Llano L, Cisneros C, Domínguez-Ortega J, Martínez-Moragón E, Olaguibel JM, Plaza V, et al. Response to monoclonal antibodies in asthma: definitions, potential reasons for failure, and therapeutic options for suboptimal response. J Investig Allergol Clin Immunol (2023) 33(1):1–13. 10.18176/jiaci.0857 - DOI - PubMed
-
- Guía Española para el Manejo del Asma. GEMA 5.3. (2023). Available online at: www.gemasma.com (accessed December 17, 2023).
-
- Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. (2023). Available online at: www.ginasthma.com (accessed December 17, 2023).
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous
